Arvest Trust CO N A Regeneron Pharmaceuticals, Inc. Transaction History

Arvest Trust CO N A

  • $1.51 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023
BUY
$700.03 - $830.35 $7,000 - $8,303
10 Added 3.5%
296 $212,000
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $2,721 - $3,307
-4 Reduced 1.38%
286 $234,000
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $204,708 - $222,253
290 New
290 $209,000

Others Institutions Holding REGN

# of Institutions
1,484
Shares Held
83.7M
Call Options Held
1.22M
Put Options Held
1.5M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Arvest Trust CO N A Portfolio

Follow Arvest Trust CO N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arvest Trust CO N A, based on Form 13F filings with the SEC.

News

Stay updated on Arvest Trust CO N A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email